Monitor for submission of compliance plan by May 26, 2026; potential reverse split or capital raise could dilute shareholders. Delisting would severely impact liquidity and institutional ownership.
Price Chart
Executive Summary
Alaunos Therapeutics (TCRT) received a delisting notice from Nasdaq due to failing to maintain the $2.5 million minimum stockholders' equity requirement, reporting $2.15 million as of December 31, 2025. The company has 45 days to submit a compliance plan and may request a hearing if needed.
Key Facts
- Received Nasdaq delisting notice on April 9, 2026, for failing to meet $2.5 million stockholders' equity requirement
- Reported stockholders' equity of $2,153,000 as of December 31, 2025
- Does not meet alternative listing standards (market value or net income)
- Has 45 days (until May 26, 2026) to submit a compliance plan
- May request a hearing to appeal if plan is rejected
Financial Impact
Stockholders' equity of $2,153,000 vs. required $2,500,000
Risk Factors
- Failure to regain compliance could lead to delisting from Nasdaq
- Reduced investor confidence and liquidity if delisted
- Potential need for dilutive financing to meet equity requirements
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-157126 |
| Document: 0001193125-26-157126-index-headers.html | 0001193125-26-157126 |
| Document: 0001193125-26-157126-index.html | 0001193125-26-157126 |
| Document: 0001193125-26-157126.txt | 0001193125-26-157126 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 29, 2026 13w ago | 8-K | $2.37 $1.27 | ▼ −46.41% | ▼ −50.80% | $0.8840 (−62.70%) |
May 26, 2026 18w ago | 8-K | $2.45 $1.88 | ▲ +23.27% | ▲ +25.99% | $0.8840 (+63.92%) |
Apr 15, 2026 24w ago | 8-K | $2.83 $2.08 | ▲ +26.36% | ▲ +33.41% | $0.8840 (+68.76%) |
Mar 2, 2026 30w ago | Press Release | $3.32 $2.45 | ▼ −26.20% | ▼ −35.53% | $0.8840 (−73.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access